Inflammatory Hepatocellular Adenoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-26
Clinical Trial Update: A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas [Phase 2]
Phase 2 open-label, single-arm trial evaluating a JAK1 inhibitor for large inflammatory hepatocellular adenomas is currently recruiting.